Combined prednisolone, azathioprine, and cyclophosphamide treatment for persistent proliferative glomerulonephritis in adults.
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use*; D002699:Chlorambucil / Q000008:administration & dosage; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006801:Humans; D007678:Kidney Glomerulus / Q000473:pathology; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use*; D011379:Prognosis; D011507:Proteinuria; D012709:Serum Albumin
D012709:Serum Albumin; D002699:Chlorambucil; D003520:Cyclophosphamide; D002784:Cholesterol; D011239:Prednisolone; D003404:Creatinine; D001379:Azathioprine